Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
Dateline Introduction – San Diego, November 10, 2025:Gallant, an animal health biotechnology leader, has achieved a pivotal regulatory milestone...
